The Feith Executive Team is pleased to announce Michelle Peralta as the new Senior Director of Strategy and Business Development for the Life Sciences Group. She will be joining the organization effective Monday, April 9th, 2019.
Michelle has a background in biology, nursing, and international business and brings over 20 years of experience in the pharmaceutical Clinical Safety and Pharmacovigilance (PV) field with senior roles at the global level. During her tenure at Takeda, she was responsible for heading-up the Post-marketing Safety Surveillance Team and overseeing the pharmacovigilance activities for over 20 products.
Most recently, Michelle served as the Director of Global Patient Safety and Pharmacovigilance Risk Management at PRA Health Sciences, establishing strategic direction for the risk management of products including the design, implementation, and evaluation of additional risk minimization tools.
Michelle is located in Highland Park, IL, a suburb of Chicago. Looking forward to her new role, Michelle comments, “I am both excited and honored to join the Feith Life Sciences Team and the important work of modernizing PV Risk Management, Drug Safety and Regulatory tracking systems. I understand the deep complexity and imminent needs in Pharma and the Life Sciences industry for modern software and more importantly I can attest to the synergistic transformations that take place when teams use them. We’re not just helping Pharma be more efficient, we’re optimizing the way they work in improving patient health.”
The Feith Team looks forward to working with Michelle to advance the Orbit platform, simplifying the tracking of safety processes and activities and building new products to help Orbit’s clients. Dan Feith, Head of the Life Sciences Division, expects that her substantial expertise will help Feith’s customers to better leverage the Orbit platform. He also plans to leverage her subject matter expertise in these complex processes to help Feith’s development teams achieve greater product advancements.
Please join us in welcoming Michelle to Feith Life Sciences.